LOSARTAN VS ATENOLOL IN HYPERTENSIVS WITH LEFT VENTRICULAR HYPERTROPHY

氯沙坦 VS 阿替洛尔治疗高血压伴左心室肥大

• 批准号: 6276010
• 负责人: BRADLEY G PHILLIPS
• 金额: $ 1.92万
• 依托单位: UNIVERSITY OF IOWA
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-12-01 至 1998-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6276010
• 关键词: antihypertensive agents; atenolol; cardiovascular function; clinical research; drug screening /evaluation; human morbidity; human mortality; human subject; hypertension; ventricular hypertrophy

This study will evaluate the long-term effects of losartan compared to atenolol in hypertensive patients with documented left ventricular hypertrophy on the combination of cardiovascular mortality and morbidity.

这项研究将评估氯沙坦与氯沙坦的长期疗效 阿替洛尔在高血压患者中的临床应用 心血管疾病死亡率与肥厚的关系 发病率。